Back to results
US 2008/0305474 A1Published application
Method and Apparatus for Using SLC2A10 Genetic Polymorphisms for Determining Peripheral Vascular Disease in Patients with Type-2 Diabetes
OwnerYuan-Tsong Chen, Lee-Ming Chuanginventors
Life of this patent
Estimating the term…
Abstract
Recent data indicate that a loss-of-function mutation of the SLC2A10 gene causes arterial tortuosity syndrome (ATS) via upregulation of the TGF-β pathway in the arterial wall, a mechanism possibly causing vascular changes associated with diabetes. It is determined that SLC2A10 (Solute carrier family 2, facilitated glucose transporter, member 10) genetic polymorphism is associated with peripheral vascular disease (PVD) in patients with type 2 diabetes.
Claims4
A method for determining comprising the step of associating SLC2A10 gene with Peripheral Vascular Disease (PVD) in type-2 diabetic individuals.
Dependencies are inferred from the claim text.